We all know there is no magic bullet for cancer. But scientists across the world are working on novel projects like cancer vaccines and newer tools like nanotechnology to conquer cancer, reports CNBC-TV18.
CytImmune is a small US-based nanotechnology company , but it has set a big goal for itself. CytImmune scientists are developing a nanotechnology-based Drug Delivery System that can target cancerous tumours leaving healthy organs and tissues untouched.
Dr Larry Tamarkin , CEO , Cytimmune, says, “These particles are especially designed with our proprietary technology.”
With the help of genomics and proteomics, experts say over the next few years, it will be easier to see a real headway in predicting and curing cancer.
READ MORE ON cancer, vaccines, CytImmune, US-based nanotechnology company, CEO, Dr Larry Tamarkin, Novartis, Merck, Genentech, Merck Germany, CEO, Elmar Schenny
ADS BY GOOGLE
video of the day
Dont see mkt going anywhere now; like Bharat Forge: Dipen